250 related articles for article (PubMed ID: 33971337)
1. Histopathological features of systemic sclerosis-associated myopathy: A scoping review.
Lefebvre F; Giannini M; Ellezam B; Leclair V; Troyanov Y; Hoa S; Bourré-Tessier J; Satoh M; Fritzler MJ; Senécal JL; Hudson M; Meyer A; Landon-Cardinal O
Autoimmun Rev; 2021 Jul; 20(7):102851. PubMed ID: 33971337
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody profiles delineate distinct subsets of scleromyositis.
Leclair V; D'Aoust J; Gyger G; Landon-Cardinal O; Meyer A; O'Ferrall E; Karamchandani J; Massie R; Ellezam B; Satoh M; Troyanov Y; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Mar; 61(3):1148-1157. PubMed ID: 34146090
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology.
Bhansing KJ; Lammens M; Knaapen HK; van Riel PL; van Engelen BG; Vonk MC
Arthritis Res Ther; 2014 May; 16(3):R111. PubMed ID: 24886750
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
5. Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.
Giannini M; Ellezam B; Leclair V; Lefebvre F; Troyanov Y; Hudson M; Senécal JL; Geny B; Landon-Cardinal O; Meyer A
Front Immunol; 2022; 13():974078. PubMed ID: 36776390
[TBL] [Abstract][Full Text] [Related]
6. Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis.
Ellezam B; Leclair V; Troyanov Y; Bersali I; Giannini M; Hoa S; Bourré-Tessier J; Nadon V; Drouin J; Karamchandani J; O'Ferrall E; Lannes B; Satoh M; Fritzler MJ; Senécal JL; Hudson M; Meyer A; Landon-Cardinal O
Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12840. PubMed ID: 35894636
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.
Paik JJ; Wigley FM; Lloyd TE; Corse AM; Casciola-Rosen L; Shah AA; Boin F; Hummers LK; Mammen AL
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1416-25. PubMed ID: 25989455
[TBL] [Abstract][Full Text] [Related]
8. Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
Yasin SA; Schutz PW; Deakin CT; Sag E; Varsani H; Simou S; Marshall LR; Tansley SL; McHugh NJ; Holton JL; Wedderburn LR; Jacques TS;
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):495-512. PubMed ID: 30378704
[TBL] [Abstract][Full Text] [Related]
9. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
[TBL] [Abstract][Full Text] [Related]
10. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
11. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort.
Matas-García A; Guillén-Del-Castillo A; Kisluk B; Selva-O'Callaghan A; Espinosa G; Prieto-González S; Moreno Lozano P; Garrabou G; Grau-Junyent JM; Simeon-Aznar CP; Milisenda JC
Rheumatology (Oxford); 2023 Feb; 62(SI):SI82-SI90. PubMed ID: 35713496
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic measures for patients with systemic sclerosis-associated myopathy.
Baumberger R; Jordan S; Distler O; Baschung Pfister P; Maurer B
Clin Exp Rheumatol; 2021; 39 Suppl 131(4):85-93. PubMed ID: 34323680
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis associated myopathy: how to treat.
Selva-O'Callaghan A; Guillen-Del-Castillo A; Gil-Vila A; Trallero-Araguás E; Matas-García A; Milisenda JC; Pinal-Fernández I; Simeón-Aznar C
Curr Treatm Opt Rheumatol; 2023 Dec; 9(4):151-167. PubMed ID: 38737329
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis-associated myopathy.
Ranque B; Authier FJ; Berezne A; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1108():268-82. PubMed ID: 17899625
[TBL] [Abstract][Full Text] [Related]
17. Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation.
Corallo C; Cutolo M; Volpi N; Franci D; Aglianò M; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
Ther Adv Musculoskelet Dis; 2017 Jan; 9(1):3-10. PubMed ID: 28101144
[TBL] [Abstract][Full Text] [Related]
18. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
19. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Ann Agric Environ Med; 2021 Mar; 28(1):189-192. PubMed ID: 33775087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
